The treatments for cervical cancer depend on its severity and type. For carcinoma in situ, or very early cancer, your doctor may kill the malignant growth through cryosurgery, laser surgery, ...

Association of Human Papillomavirus With Vulvar and Vaginal Intraepithelial Disease: Opportunities for Prevention ...

Brachytherapy Awareness Day highlights the value of this precise form of internal radiotherapy in treating cancer. Organised by several oncology organisations, the initiative showcases evidence that ...

Extrapolating potential reduction in cervical cancers from direct and cross-protection of the HPV vaccines under assumptions of complete vaccine coverage, lifetime duration of efficacy and ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Cervical cancer is one of the most common gynecologic cancers worldwide and continues to be a leading cause of cancer-related ...

Cervical Adenocarcinoma and Related Neoplasms Publication Trend The graph below shows the total number of publications each year in Cervical Adenocarcinoma and Related Neoplasms.

Tislelizumab combined with chemotherapy shows promising antitumor activity in advanced cervical cancer, achieving high response rates and manageable safety profiles.

The tumour was diagnosed as a "Stage 0" adenocarcinoma in situ. Precancerous cells in the colon and pancreas were also detected among six people in the survey, according to the company.